Skip to main content
Watch Insiders

Corporate insider profile

Helen Louise Collins Insider Trades

Latest reported as CHIEF MEDICAL OFFICER of Enliven Therapeutics, Inc. (ELVN).

Purchase filings
0
Reported companies
1
Net open-market value
-$1,656,741.50
Latest transaction
Oct 19, 2026

Affiliated corporations

Reported company relationships

ELVNLatest reported

Enliven Therapeutics, Inc.

CHIEF MEDICAL OFFICER

Transaction history

Open-market Transactions

Open-market insider purchase and sale transactions
DateCompanyRoleTypeSharesPriceTotal value
Oct 19, 2026Enliven Therapeutics, Inc. (ELVN)CHIEF MEDICAL OFFICERSale5,000$38.47$192,342
Sep 17, 2026Enliven Therapeutics, Inc. (ELVN)CHIEF MEDICAL OFFICERSale5,000$50.35$251,754
Aug 17, 2026Enliven Therapeutics, Inc. (ELVN)CHIEF MEDICAL OFFICERSale5,000$58.59$292,931
Jul 17, 2026Enliven Therapeutics, Inc. (ELVN)CHIEF MEDICAL OFFICERSale5,000$52.67$263,374
Jun 17, 2026Enliven Therapeutics, Inc. (ELVN)CHIEF MEDICAL OFFICERSale5,000$43.80$219,017
May 18, 2026Enliven Therapeutics, Inc. (ELVN)CHIEF MEDICAL OFFICERSale5,000$39.79$198,972
Apr 17, 2026Enliven Therapeutics, Inc. (ELVN)CHIEF MEDICAL OFFICERSale5,000$47.67$238,353